SCHEMBL14586201

SCHEMBL14586201

CC(C)(C)OC(=O)N[C@H]1CC/C=C/[C@@H]2C[C@@]2(C(=O)O)NC(=O)[C@@H]2CC(Oc3nccc4ccccc34)CN2C1=O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.48
▸ ADRB3 P13945 1/20 0.44
▸ ADRA2B P18089 1/20 0.44
▸ ADRA2C P18825 1/20 0.44
▸ HCRTR1 O43613 1/20 0.33
▸ HCRTR2 O43614 1/20 0.33
▸ JAK2 O60674 1/20 0.31
▸ JAK1 P23458 1/20 0.31
▸ CTSB P07858 1/20 0.31
▸ KDM4D Q6B0I6 1/20 0.31
▸ BTK Q06187 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ SSTR1 P30872 1/20 0.30
▸ SSTR4 P31391 1/20 0.30
▸ GRM4 Q14833 1/20 0.30
▸ ROCK2 O75116 1/20 0.30
▸ CCKBR P32239 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14586199 1.00 CYP3A4 (0.48) CYP3A4ADRB3ADRA2BADRA2CHCRTR1
SCHEMBL8300307 0.95 ADRB3 (0.50) CYP3A4ADRB3ADRA2BADRA2CHCRTR1
SCHEMBL3698151 0.95 ADRB3 (0.50) CYP3A4ADRB3ADRA2BADRA2CHCRTR1
Ether SCHEMBL3695176 0.92 ADRB3 (0.47) CYP3A4ADRB3ADRA2BADRA2CHCRTR1
SCHEMBL8305648 0.87 CYP3A4 (0.46) CYP3A4ADRB3ADRA2BADRA2CHCRTR1
SCHEMBL3693821 0.87 CYP3A4 (0.46) CYP3A4ADRB3ADRA2BADRA2CHCRTR1
SCHEMBL5564319 0.87 CYP3A4 (0.46) CYP3A4ADRB3ADRA2BADRA2CHCRTR1
SCHEMBL5564314 0.87 CYP3A4 (0.46) CYP3A4ADRB3ADRA2BADRA2CHCRTR1
SCHEMBL13757833 0.87 CYP3A4 (0.40) CYP3A4ADRB3ADRA2BADRA2CHCRTR1
SCHEMBL3701675 0.87 CYP3A4 (0.50) CYP3A4ADRB3ADRA2BADRA2CCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7173004-B2 Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus BRISTOL-MYERS SQUIBB COMPANY (US) 2007-02-06 — — US disclosed
Send feedback